4.7 Article

The 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol

Journal

CIRCULATION RESEARCH
Volume 114, Issue 5, Pages 761-764

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.114.303398

Keywords

cardiovascular disease; cholesterol; diabetes; guidelines; low-density-lipoprotein; risk; treatment

Funding

  1. AstraZeneca
  2. Boerhinger-Ingelheim
  3. BristolMyersSquibb
  4. Genentech/Roche
  5. Genzyme
  6. ISIS
  7. Janssen
  8. Kowa
  9. Merck
  10. Novartis
  11. Pfizer
  12. Regeneron
  13. Sanofi

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available